BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30467241)

  • 1. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
    Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
    J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
    Nevel KS; Wilcox JA; Robell LJ; Umemura Y
    Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
    Escudero L; Martínez-Ricarte F; Seoane J
    Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors.
    Takayasu T; Shah M; Dono A; Yan Y; Borkar R; Putluri N; Zhu JJ; Hama S; Yamasaki F; Tahara H; Sugiyama K; Kurisu K; Esquenazi Y; Ballester LY
    Sci Rep; 2020 Aug; 10(1):14326. PubMed ID: 32868820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
    Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
    Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies.
    Momtaz P; Pentsova E; Abdel-Wahab O; Diamond E; Hyman D; Merghoub T; You D; Gasmi B; Viale A; Chapman PB
    Oncotarget; 2016 Dec; 7(51):85430-85436. PubMed ID: 27863426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
    Verheul C; Kleijn A; Lamfers MLM
    Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.
    Seoane J; De Mattos-Arruda L; Le Rhun E; Bardelli A; Weller M
    Ann Oncol; 2019 Feb; 30(2):211-218. PubMed ID: 30576421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
    Yan W; Xu T; Zhu H; Yu J
    Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
    Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
    Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies.
    Shah M; Takayasu T; Zorofchian Moghadamtousi S; Arevalo O; Chen M; Lan C; Duose D; Hu P; Zhu JJ; Roy-Chowdhuri S; Riascos RF; Chen H; Luthra R; Esquenazi Y; Ballester LY
    J Mol Diagn; 2021 Feb; 23(2):171-180. PubMed ID: 33531134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
    Li YS; Zheng MM; Jiang BY; Tu HY; Yang JJ; Zhang XC; Wu YL
    JAMA Netw Open; 2020 Aug; 3(8):e209077. PubMed ID: 32749467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
    Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
    Liu AP; Northcott PA; Robinson GW; Gajjar A
    Lab Invest; 2022 Feb; 102(2):134-142. PubMed ID: 34934181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
    von Baumgarten L; Kumbrink J; Jung A; Reischer A; Flach M; Liebmann S; Metzeler KH; Holch JW; Niyazi M; Thon N; Straube A; von Bergwelt-Baildon M; Heinemann V; Kirchner T; Westphalen CB
    Theranostics; 2020; 10(2):856-866. PubMed ID: 31903155
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
    Mattox AK; Yan H; Bettegowda C
    Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
    Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
    Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.
    Watanabe J; Natsumeda M; Kanemaru Y; Okada M; Oishi M; Kakita A; Fujii Y
    Leuk Lymphoma; 2019 Dec; 60(14):3587-3589. PubMed ID: 31305194
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
    Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
    Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.